Biography

Prof. Xiao-Feng Li

Chairman of Department of Nuclear Medicine

Shenzhen People’s Hospital, Shenzhen, China

Professor


Email: [email protected]


Qualifications

2003 Ph.D., Kanazawa University Graduate School of Medical Sciences
1993 M.D., Norman Bethune University of Medical Sciences


Publications (selected)

  1. Li J, Zhang G, Zhu M, et al. Establishment and Imaging Studies of Human Lung Cancer-Associated Brain Metastasis Animal Models[J]. Journal of Medical Imaging and Health Informatics, 2019, 9(6): 1138–1141.
  2. Sokhadze E M, Casanova M F, Casanova E, et al. Applications of ERPs in autism research and as functional outcomes of neuromodulation treatment[M] // Event-Related Potential (ERP): Methods, Outcomes and Research Insights. 2017: 27–87.
  3. Sokhadze E M, Casanova M F, El-Baz A S, et al. TMS-based neuromodulation of evoked and induced gamma oscillations and event-related potentials in children with autism[J]. NeuroRegulation, 2016, 3(3): 101–101.
  4. Zhang Q, Du Y, Jing L, et al. Infra red dye and endostar loaded poly lactic acid nano particles as a novel theranostic nanomedicine for breast cancer[J]. Journal of Biomedical Nanotechnology, 2016, 12(3): 491–502.
  5. Luo R, Niu L, Qiu F, et al. Monitoring apoptosis of breast cancer xenograft after paclitaxel treatment with 99mTc-labeled duramycin SPECT/CT[J]. Molecular Imaging, 2016, 15: 1536012115624918.
  6. Zhang G, Li XF. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: A pilot study[J]. Journal of Nuclear Medicine, 2015, 56: 607–612.
  7. Li J, Li XF. Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?[J]. Future Oncology, 2015, 11(10): 1531–1541.
  8. Zhang X, Xin J, Shi Y, et al. Assessing activation of hepatic stellate cells by 99mTc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study[J]. Nuclear Medicine and Biology, 2015, 42(3): 250–255.
  9. Cheng P H, Rao X M, Wechman S L, et al. Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice[J]. BMC Cancer, 2015, 15(1): 716.
  10. Li XF, et al. 18F-fluorodeoxyglucose uptake and tumor hypoxia: Revisit 18F-fluorodeoxyglucose in oncology application[J]. Translational Oncology, 2014, 7: 240–247.
  11. Huang T, Li XF. 18F-misonidazole PET imaging hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: Correlating with autoradiographic and histological findings[J]. American Journal of Nuclear Medicine and Molecular Imaging, 2013, 3(2): 142–153.
  12. Li XF, et al. Combination of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET achieves more complete identification of viable cancer cells in lung cancer of the mouse and the patient than individual radiopharmaceutical: A proof-of-concept study[J]. Translational Oncology, 2013, 6: 775–783.
  13. Huang T, Li XF. Tumor microenvironment–dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: A pilot study in mouse models of human non–small cell lung cancer[J]. Journal of Nuclear Medicine, 2012, 53: 1262–1268.
  14. Li XF, O’Donoghue JA. High 18F-FDG uptake in microscopic peritoneal tumors requires physiological hypoxia[J]. Journal of Nuclear Medicine, 2010, 51: 632–638.
  15. Li XF, O’Donoghue JA. Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside digital autoradiography[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37: 339–348.
  16. Li XF, O’Donoghue JA. Hypoxia in microscopic tumors[J]. Cancer Letters, 2008, 264: 172–180.
  17. Li XF, O’Donoghue JA. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy[J]. Cancer Research, 2007, 67(16): 7646–7653.
  18. Li XF, Zanzonico P B, Ling C C, et al. Visualization of experimental lung and bone metastases in live nude mice by X-ray micro-computed tomography[J]. Technology in Cancer Research & Treatment, 2006, 5: 147–155.
  19. Li XF, et al. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29: 1669–1674.



Profile Details

https://loop.frontiersin.org/people/1003026/overview

https://www.researchgate.net/profile/Xiao-Feng-Li-5

https://pubmed.ncbi.nlm.nih.gov/37711813/


SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top